Anbio Biotechnology revenue was $8.19M for the trailing 12 months ending Dec 31, 2024, with -46.7% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NNNN annual revenue was $8.2M, with 21.9% growth year-over-year.
NNNN past revenue growth
How has NNNN's revenue growth performed historically?
Anbio Biotechnology (NASDAQ: NNNN) reported Q4 2024 revenue of N/A up N/A year over year. In the same quarter last year, Anbio Biotechnology's revenue was N/A.
What was Anbio Biotechnology's revenue in 2024?
Anbio Biotechnology's annual revenue for the twelve months ending Dec 31, 2024 was $8.19 million, a 21.95% increase year over year.
How much does Anbio Biotechnology make in a day?
Based on Anbio Biotechnology annual revenue for the past two years, NNNN makes an average of $20,407.04 per day.
What was Anbio Biotechnology's annual revenue growth in the past year?
As of Q2 2025, Anbio Biotechnology's revenue has grown 21.95% year over year. This is 415.36 percentage points lower than the US Biotechnology industry revenue growth rate of 437.31%. Anbio Biotechnology's revenue in the past year totaled $8.19 million.
How much does Anbio Biotechnology make in a year?
Anbio Biotechnology's revenue by year for the past two years is:
Anbio Biotechnology's revenue for the twelve months ending Dec 31, 2024 was $8.19 million, a 21.95% increase year over year.
Anbio Biotechnology's annual revenue for Dec 31, 2023 was $6.71 million, a 71.49% decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.